BLMH.c will eclipse yearly guidance with Q4 earnings. Bloom Health Partners (CSE: BLMH) recent expansion into Hawaii bodes well for the company to eclipse its yearly earnings guidance.
Bloom reported earlier this year that it foresees yearly revenue of $25M—$28M. Currently, in the last 3 quarters, the company has recorded revenues of $24.9 million. If the company is able to realize earnings similar to these past 3 quarters, which it seems like they will, earnings will total well over $30M.
For a company currently valued at only $9.06, this represents a massive undervaluation. The average price to sales ratio for companies in Bloom’s industry is ~4. This means, with yearly earnings of ~30M, Bloom should be valued ~$120M.
BLMH.c is currently trading at $.19.
https://ceo.ca/@newsfile/bloom-health-partners-announces-new-location-in-hawaii